{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:04:57Z","timestamp":1791180297801,"version":"4.1.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/md.0b013e3181b76ab5","type":"journal-article","created":{"date-parts":[[2009,9,8]],"date-time":"2009-09-08T07:12:49Z","timestamp":1252393969000},"page":"284-293","source":"Crossref","is-referenced-by-count":245,"title":["Hematologic Manifestations and Predictors of Lymphoma Development in Primary Sj\u00f6gren Syndrome"],"prefix":"10.1097","volume":"88","author":[{"given":"Evangelia","family":"Baimpa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa J.","family":"Dahabreh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Voulgarelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haralampos M.","family":"Moutsopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210226","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/ard.2002.001826","article-title":"Hepatic manifestations of autoimmune rheumatic diseases.","volume":"63","author":"Abraham","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R2-4-20210226","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/rheumatology\/kei107","article-title":"Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982-2003.","volume":"45","author":"Alamanos","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R3-4-20210226","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5","article-title":"What do we mean by validating a prognostic model?","volume":"19","author":"Altman","year":"2000","journal-title":"Stat Med"},{"key":"R4-4-20210226","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0962280206074466","article-title":"A comparison of imputation techniques for handling missing predictor values in a risk model with a binary outcome.","volume":"16","author":"Ambler","year":"2007","journal-title":"Stat Methods Med Res"},{"key":"R5-4-20210226","first-page":"1589","article-title":"Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study.","volume":"30","author":"Andrianakos","year":"2003","journal-title":"J Rheumatol"},{"key":"R6-4-20210226","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/ndt\/16.12.2328","article-title":"Clinical and morphological features of kidney involvement in primary Sjogren's syndrome.","volume":"16","author":"Bossini","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R7-4-20210226","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/03009740310004676","article-title":"Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK.","volume":"33","author":"Bowman","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"R9-4-20210226","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3816\/CLM.2005.n.012","article-title":"Clinical characteristics and outcome of immunoglobulin M-related disorders.","volume":"5","author":"Cesana","year":"2005","journal-title":"Clin Lymphoma"},{"key":"R10-4-20210226","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/ard.62.5.476","article-title":"Primary Sjogren's syndrome associated agranulocytosis: a benign disorder?","volume":"62","author":"Coppo","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"Series B","key":"R11-4-20210226","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"R12-4-20210226","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/ard.56.9.521","article-title":"Prevalence of Sjogren's syndrome in a closed rural community.","volume":"56","author":"Dafni","year":"1997","journal-title":"Ann Rheum Dis"},{"key":"R13-4-20210226","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1182\/blood-2006-06-030494","article-title":"MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation.","volume":"109","author":"Deutsch","year":"2007","journal-title":"Blood"},{"key":"R14-4-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/aos\/1176344552","article-title":"Bootstrap methods: another look at the jackknife.","volume":"7","author":"Efron","year":"1979","journal-title":"Ann Stat"},{"key":"R15-4-20210226","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.","volume":"111","author":"Ekstrom Smedby","year":"2008","journal-title":"Blood"},{"key":"R16-4-20210226","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sjogren's syndrome.","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"R17-4-20210226","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/sarh.2002.31547","article-title":"Agranulocytosis in Sjogren's syndrome: two case reports and analysis of 11 additional reported cases.","volume":"31","author":"Friedman","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"R18-4-20210226","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1200\/JCO.2006.07.5671","article-title":"Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.","volume":"24","author":"Ghesquieres","year":"2006","journal-title":"J Clin Oncol"},{"key":"R19-4-20210226","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/archneur.63.11.1612","article-title":"Peripheral neuropathy in primary sjogren syndrome: a population-based study.","volume":"63","author":"Goransson","year":"2006","journal-title":"Arch Neurol"},{"key":"R20-4-20210226","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals.","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"R21-4-20210226","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome.","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R22-4-20210226","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1164\/rccm.200403-417OC","article-title":"Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study.","volume":"171","author":"Ito","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R24-4-20210226","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R25-4-20210226","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","article-title":"Clinical manifestations and early diagnosis of Sjogren syndrome.","volume":"164","author":"Kassan","year":"2004","journal-title":"Arch Intern Med"},{"key":"R26-4-20210226","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome.","volume":"89","author":"Kassan","year":"1978","journal-title":"Ann Intern Med"},{"key":"R27-4-20210226","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1018472213872","article-title":"Elevated incidence of hematologic malignancies in patients with Sjogren's syndrome compared with patients with rheumatoid arthritis (Finland).","volume":"8","author":"Kauppi","year":"1997","journal-title":"Cancer Causes Control"},{"key":"R28-4-20210226","first-page":"609","article-title":"CD4+ T-lymphocytopenia without HIV infection: increased prevalence among patients with primary Sjogren's syndrome.","volume":"13","author":"Kirtava","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"R29-4-20210226","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/rheumatology\/kei281","article-title":"Incidence of cancer in a cohort of patients with primary Sjogren's syndrome.","volume":"45","author":"Lazarus","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R30-4-20210226","first-page":"726","article-title":"CD4+ T-lymphocytopenia-a frequent finding in anti-SSA antibody seropositive patients with primary Sjogren's syndrome.","volume":"31","author":"Mandl","year":"2004","journal-title":"J Rheumatol"},{"key":"R31-4-20210226","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/ard.60.11.1007","article-title":"Lymphomas complicating Sjogren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells.","volume":"60","author":"Mariette","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R32-4-20210226","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/art.23267","article-title":"Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma.","volume":"58","author":"Mellemkjaer","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R33-4-20210226","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/sj.leu.2403442","article-title":"Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.","volume":"18","author":"Morra","year":"2004","journal-title":"Leukemia"},{"key":"R35-4-20210226","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/clin.1994.1123","article-title":"Sjogren's syndrome: autoimmune epithelitis.","volume":"72","author":"Moutsopoulos","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"R36-4-20210226","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods.","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"R37-4-20210226","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.","volume":"30","author":"Owen","year":"2003","journal-title":"Semin Oncol"},{"key":"R38-4-20210226","first-page":"337","article-title":"Non-Hodgkin's lymphoma associated with primary Sjogren's syndrome.","volume":"1","author":"Pariente","year":"1992","journal-title":"Eur J Med"},{"key":"R39-4-20210226","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00005792-200207000-00004","article-title":"Primary Sjogren syndrome: hematologic patterns of disease expression.","volume":"81","author":"Ramos-Casals","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"R40-4-20210226","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood.V90.2.766","article-title":"Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses.","volume":"90","author":"Royer","year":"1997","journal-title":"Blood"},{"key":"R41-4-20210226","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome.","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"key":"R42-4-20210226","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.","volume":"98","author":"Smedby","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R43-4-20210226","first-page":"1046","article-title":"Advances in the diagnosis and concept of Sjogren's syndrome (autoimmune exocrinopathy).","volume":"30","author":"Strand","year":"1979","journal-title":"Bull Rheum Dis"},{"key":"R44-4-20210226","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0049-0172(98)80040-1","article-title":"Predictors of lymphoma development in primary Sjogren's syndrome.","volume":"28","author":"Sutcliffe","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"R45-4-20210226","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sjogren's syndrome: a cohort study on cancer incidence and lymphoma predictors.","volume":"65","author":"Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R46-4-20210226","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","article-title":"Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study.","volume":"50","author":"Theander","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R47-4-20210226","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/ard.2004.031021","article-title":"Sjogren's syndrome: a population based study of prevalence in Greece. The ESORDIG study.","volume":"64","author":"Trontzas","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R48-4-20210226","first-page":"2376","article-title":"Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjogren's syndrome.","volume":"24","author":"Valesini","year":"1997","journal-title":"J Rheumatol"},{"key":"R49-4-20210226","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R50-4-20210226","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","article-title":"Malignant lymphoma in primary Sjogren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren's Syndrome.","volume":"42","author":"Voulgarelis","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R51-4-20210226","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/1529-0131(199908)42:8<1673::AID-ANR16>3.0.CO;2-1","article-title":"Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjogren's syndrome.","volume":"42","author":"Zeher","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R52-4-20210226","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis.","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"key":"R53-4-20210226","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","article-title":"Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.","volume":"101","author":"Zucca","year":"2003","journal-title":"Blood"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0b013e3181b76ab5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T01:08:52Z","timestamp":1739322532000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-200909000-00004"}},"subtitle":["Clinical and Pathophysiologic Aspects"],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3181b76ab5","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}